ChartRow logo
ChartRow
Stocks and ETFs

financial statements

The full income statement, balance sheet, and cash-flow statement for Boston Scientific Corporation (BSX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

See the live BSX chart & snapshot →

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue
20.1B
YoY+19.9%
16.7B
YoY+17.6%
14.2B
YoY+12.3%
12.7B
YoY+6.7%
11.9B
YoY+19.9%
13.9B
YoY+20.6%
11.5B
YoY+16.1%
9.90B
YoY+13.4%
8.73B
YoY+6.7%
8.18B
YoY+26.8%
10.2B
YoY+15.2%
8.89B
YoY+17.7%
7.55B
YoY+6.7%
7.08B
YoY+1.4%
6.98B
YoY+6.9%
Operating income
3.61B
YoY+38.8%
2.60B
YoY+11.1%
2.34B
YoY+42.1%
1.65B
YoY+37.5%
1.20B
YoY+1598.8%
Interest expense
349M
YoY+14.4%
305M
YoY+15.1%
265M
YoY-43.6%
470M
YoY+37.8%
341M
YoY-5.5%
Other non-operating income
-228M
YoY+29.0%
-321M
YoY+10.3%
-358M
YoY+29.5%
-508M
YoY-333.0%
218M
YoY-39.8%
Pre-tax income
3.38B
YoY+48.3%
2.28B
YoY+15.0%
1.99B
YoY+74.0%
1.14B
YoY+6.0%
1.08B
YoY+1462.0%
Income tax
493M
YoY+13.1%
436M
YoY+10.9%
393M
YoY-11.3%
443M
YoY+1130.6%
36.0M
YoY+1700.0%
2.89B
YoY+56.7%
1.85B
YoY+16.0%
1.59B
YoY+128.1%
698M
YoY-32.9%
1.04B
YoY+1369.5%
$1.94
YoY+55.2%
$1.25
YoY+16.8%
$1.07
YoY+137.8%
$0.45
YoY-34.8%
$0.69
YoY+962.5%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
8.79B
YoY+27.1%
6.92B
YoY+6.2%
6.51B
YoY+13.1%
5.76B
YoY-8.8%
6.32B
YoY-5.6%
43.7B
YoY+10.9%
39.4B
YoY+12.1%
35.1B
YoY+8.2%
32.5B
YoY+0.7%
32.2B
YoY+4.7%
5.44B
YoY-15.0%
6.40B
YoY+29.7%
4.93B
YoY+29.7%
3.80B
YoY-11.0%
4.27B
YoY+16.1%
Long-term debt
4.81B
YoY+0.0%
4.81B
YoY+0.0%
4.81B
YoY+0.0%
4.81B
YoY+0.0%
4.81B
YoY+0.0%
Non-current lease liability
446M
YoY+11.2%
401M
YoY+2.8%
390M
YoY+12.4%
347M
YoY-10.8%
389M
YoY-3.0%
Deferred tax liabilities
220M
YoY+41.9%
155M
YoY+15.7%
134M
YoY-6.9%
144M
YoY-53.5%
310M
YoY-6.1%
Other non-current liabilities
2.40B
YoY+28.6%
1.87B
YoY-4.9%
1.97B
YoY-3.3%
2.04B
YoY-8.3%
2.22B
YoY-3.9%
24.2B
YoY+11.3%
21.8B
YoY+12.9%
19.3B
YoY+9.7%
17.6B
YoY+5.7%
16.6B
YoY+8.5%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
4.53B
YoY+32.0%
3.44B
YoY+37.2%
2.50B
YoY+64.0%
1.53B
YoY-18.4%
1.87B
YoY+24.0%
-2.64B
YoY+53.6%
-5.69B
YoY-120.9%
-2.57B
YoY-28.0%
-2.01B
YoY-25.9%
-1.60B
YoY-288.6%
-395M
YoY-121.8%
1.81B
YoY+36180.0%
5.00M
YoY+100.9%
-548M
YoY-476.8%
-95.0M
YoY-132.4%
FX effect on cash
42.0M
YoY+481.8%
-11.0M
YoY-175.0%
-4.00M
YoY+55.6%
-9.00M
YoY-50.0%
-6.00M
YoY-200.0%
Net change in cash
1.54B
YoY+442.4%
-450M
YoY-542.9%
-70.0M
YoY+93.3%
-1.04B
YoY-702.3%
173M
YoY-87.5%
Interest paid
319M
YoY+27.6%
250M
YoY-3.5%
259M
YoY-42.4%
450M
YoY+33.1%
338M
YoY-5.8%
Income taxes paid
561M
YoY-14.5%
656M
YoY+28.1%
512M
YoY-22.7%
662M
YoY+119.2%
302M
YoY+45.9%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
141B
YoY+7.4%
132B
YoY+55.4%
84.7B
YoY+27.8%
66.3B
YoY+9.5%
60.5B
YoY+17.6%
P/E
48.9×
YoY-31.5%
71.3×
YoY+3.5%
68.9×
YoY-32.0%
101.4×
YoY+74.4%
58.1×
P/S
7.0×
YoY-10.4%
7.9×
YoY+27.8%
6.2×
YoY+16.7%
5.3×
YoY+3.5%
5.1×
YoY-1.9%
P/B
5.8×
YoY-3.5%
6.0×
YoY+34.9%
4.5×
YoY+19.4%
3.8×
YoY+3.1%
3.6×
YoY+8.4%
P/FCF
38.6×
YoY-22.4%
49.8×
YoY-0.2%
49.9×
YoY-58.2%
119.4×
YoY+159.5%
46.0×
YoY+1.2%
Earnings yield
2.0%
YoY+45.9%
1.4%
YoY-3.3%
1.5%
YoY+47.2%
1.0%
YoY-42.7%
1.7%
FCF yield
2.6%
YoY+28.8%
2.0%
YoY+0.2%
2.0%
YoY+139.3%
0.8%
YoY-61.5%
2.2%
YoY-1.1%
Source filing10-K10-K10-K10-K10-K

About this data

Source: BSX's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all BSX filings on SEC EDGAR → Not investment advice.